A Randomized Trial of Punctuated Antiretroviral Therapy in Ugandan HIV-Seropositive Adults With Pulmonary Tuberculosis and CD4(+) T-Cell Counts of ≥350 cells/μL

Background. Optimal treatment of human immunodeficiency virus (HIV)–associated tuberculosis in patients with high CD4(+) T-cell counts is unknown. Suppression of viral replication during therapy for tuberculosis may block effects of immune activation on T cells and slow HIV disease progression. Meth...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nanteza, M. W., Mayanja-Kizza, H., Charlebois, E., Srikantiah, P., Lin, R., Mupere, E., Mugyenyi, P., Boom, W. H., Mugerwa, R. D., Havlir, D. V., Whalen, C. C.
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2011
Materias:
Major Articles and Brief Reports
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3156928/
https://ncbi.nlm.nih.gov/pubmed/21849285
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jir503
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares